The American Diabetes Association(ADA), has applauded U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) for recently introducing legislation which aims to make insulin more affordable for millions of Americans with diabetes.
Insulin costs 10 times more in the U.S. than anywhere else in the world, and as many as 1 in 4 US insulin users report rationing their insulin – skipping doses or taking less than they need, putting themselves at risk for serious complications. With the rising cost of insulin now being seen as unsustainable, the ADA has long advocated for reform of the prescription drug rebate system that inflates the cost of insulin.
The bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act includes important reforms to reduce the price of insulin by incentivising lower list prices and including limits on out-of-pocket costs for patients.
“We applaud the commitment of Senators Shaheen and Collins to finally make insulin affordable at a national level and we thank them for their leadership in legislation that includes important reforms to reduce the price of insulin by incentivizing lower list prices and include limits on out-of-pocket costs,” said Lisa Murdock, chief advocacy officer of the American Diabetes Association. “Critically, these provisions would help both the insured and the uninsured patient communities.”
To read more, CLICK HERE.